CompletedNot Applicable

Calypso Knee System Clinical Study

United States81 participantsStarted 2018-09-19

Plain-language summary

A clinical study to evaluate the safety and effectiveness of the Calypso Knee System when used in subjects with symptomatic osteoarthritis of the medial compartment of the knee.

Who can participate

Age range25 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Participants age - 25 to 65 years
✓. Body Mass Index (BMI) of \< 35, Weight \< 300 lbs
✓. Knee osteoarthritis pain on the inner side of knee that has continued after at least 6 months of non-operative treatment

Exclusion criteria

✕. Symptoms of osteoarthritis in the other knee or in lateral (outer) or patellofemoral compartments of the target knee
✕. Knee ligament or meniscal instability
✕. Other bone or joint conditions such as Rheumatoid arthritis, Paget's disease, Charcot's disease or general conditions such as allergy or hypersensitivity to certain metals, active infection, certain neurological conditions, use of medication such as steroids or chemotherapy that could impact study participation or results

What they're measuring

Composite Clinical Success (CCS)

Timeframe: From baseline to 24 months

Trial details

NCT IDNCT03671213

SponsorMoximed

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-01-17

Results submitted2023-05-02

View on ClinicalTrials.gov More Osteoarthritis, Knee trials